Arca Biopharma | ABIO - Assets

Arca Biopharma reported $54.92M in Assets for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Assets Change
Amgen AMGN:US USD 65.12B 1.42B
Biogen BIIB:US USD 24.55B 300.1M
Brainstorm Cell Therapeutics BCLI:US USD 13.25M 5.71M
Capricor Therapeutics CAPR:US USD 50.1M 3.83M
Cytokinetics CYTK:US USD 1.01B 61.19M
Cytrx CYTR:US USD 6.56M 2.16M
Daiichi Sankyo 4568:JP JPY 2.4T 29.74B
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Laboratory Of America LH:US USD 20.16B 329.1M
Myriad Genetics MYGN:US USD 1.2B 13.3M
Otsuka Holdings 4578:JP JPY 3.1T 85.02B
United Therapeutics UTHR:US USD 6.04B 262.9M